ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

ASCO Guidelines On CSFs Call For Use In Fewer Patients

December 2, 1994

New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance

July 27, 1984

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

April 18, 2014

In Brief: Less Hazardous Cigarette Only Hope To Reduce Smoking Health Problems, Carter Advisor Says

November 25, 1977

Budget Process for FY ’81 Starts; Investigators Initiated Definition May Be Heated Issues

August 31, 1979

QOL Of Anemic Patients Improved With Darbepoetin

June 28, 2002